44P Biomarker analysis from a phase Ib, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into metastatic and primary liver tumors
Titel:
44P Biomarker analysis from a phase Ib, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into metastatic and primary liver tumors
Auteur:
Hecht, J.R. Peeters, M. Martin Jimenez, M. Pless, M. Cubillo, A. Garcia-Corbacho, J. Mach, N. Digklia, A. Park, H. Subbiah, V. Gorski, K. Anderson, A. Liu, C. Snyder, W. Chesney, J.